Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1998
06/02/1998CA1339895C Piperidinoalkyl derivatives of carboxylic acid amides
05/1998
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022494A2 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
05/28/1998WO1998022493A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022467A1 New process for the preparation of morphinans
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022459A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022441A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
05/28/1998WO1998022433A1 N-(ARYL/HETEROARYL/ALKYLACETYL) AMINO ACID AMIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022430A1 N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING b-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022127A1 Pretreatment with growth factors to protect against cns damage
05/28/1998WO1998022104A2 Treatment of neurodegenerative conditions with nimesulide
05/28/1998WO1998021958A1 Nefazodone: use in treating post traumatic stress disorder
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998DE19648793A1 Neue Benzamide und deren Anwendung New benzamides and their application
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2272433A1 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis
05/28/1998CA2272385A1 Nefazodone: use in treating post traumatic stress disorder
05/28/1998CA2272249A1 Treatment of neurodegenerative conditions with nimesulide
05/28/1998CA2272065A1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
05/28/1998CA2272050A1 Secreted proteins and polynucleotides encoding them
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2270876A1 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
05/28/1998CA2269910A1 New process for the preparation of morphinans
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998CA2267634A1 Methods and compounds for inhibiting .beta.-amyloid peptide release and/or synthesis
05/28/1998CA2267065A1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositionscomprising same, and methods for inhibiting beta-amyloid peptide release a nd/or its synthesis by use of such compounds
05/28/1998CA2266659A1 Pretreatment with growth factors to protect against cns damage
05/28/1998CA2217168A1 A polypeptide, and a dna sequence to which a protein containing the polypeptide binds
05/27/1998EP0844000A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis
05/27/1998EP0843726A1 Opioid antagonists and methods of their use
05/27/1998EP0843679A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
05/27/1998EP0843675A1 Aza-anthracyclinone derivatives
05/27/1998EP0843672A1 One pot synthesis of 2-oxazolidinone derivatives
05/27/1998EP0843670A1 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof
05/27/1998EP0843661A1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
05/27/1998EP0843660A1 Heterocyclic compounds, their preparation and use
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0843516A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/27/1998EP0720551B1 Hydraulic system for anti-lock braking installations in motor vehicles
05/27/1998EP0687268B1 Spiroazacyclic derivatives as substance p antagonists
05/27/1998EP0596937B1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same
05/27/1998EP0587571B1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN
05/27/1998CN1183041A Indazolecarboxamides
05/27/1998CN1182737A New 2-(1H) -quinolinone compounds, process for preparing them and pharmaceutical compositions containing them
05/27/1998CN1182617A Medicine for curing epilepsy and preparation method thereof
05/27/1998CN1182588A Usage of schube thinamine in the preparation of medicinal composition for treating mental montional and psychological intelligent diseases
05/27/1998CN1038511C Imidazopyridine and preparation process and its pharmaceutic usage
05/27/1998CN1038510C Process for the synthesis of ergoline derivatives
05/27/1998CN1038506C Preparation process of acylaminoindole derivatives
05/27/1998CA2216625A1 Novel compounds
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756745 Preparation of nalbuphine having low levels of β-epimer
05/26/1998US5756669 Mutants
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756538 Reducing the sedative and relaxant side effect
05/26/1998US5756532 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
05/26/1998US5756530 3,4-substituted pyrazoles for the treatment of inflammation
05/26/1998US5756520 Compounds with analgesic and local anaesthetic effect
05/26/1998US5756515 Brain disorders; nervous system disorders
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756496 Drugs for treating central nervous system disorder
05/26/1998US5756495 Nervous system disorders; alzheimer's disease
05/26/1998US5756494 Protein kinase inhibitors for treatment of neurological disorders
05/26/1998US5756483 Pharmaceutical compositions for intranasal administration of apomorphine
05/26/1998US5756468 Lyophilized solid drug consists of a compound having botulinum toxicity, stabilizing protein, polysaccharide sugar and thioalkyl compound selected from methionine and cysteine; storage stability
05/26/1998US5756466 Inhibitors of interleukin-1β converting enzyme
05/26/1998US5756457 Neural regeneration using human bone morphogenetic proteins
05/26/1998US5756456 Methods involving sensory and motor neuron derived factor (SMDF)
05/26/1998US5756310 Culture product
05/26/1998US5756125 Immediate and delayed analgesic therapy
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/26/1998US5755237 Intravenous injection
05/26/1998CA2044484C Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998WO1998021206A1 Piperidine derivatives
05/22/1998WO1998021200A1 Certain pyrazole derivatives as corticotropin-releasing factor receptor crf1 specific ligands
05/22/1998WO1998021195A1 Indene inhibitors of cox-2
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998020893A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020892A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020891A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020875A1 5-ht1f agonists
05/22/1998WO1998020870A1 Improved treatment of migraine headache
05/22/1998WO1998020736A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES
05/22/1998WO1998015277A3 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents
05/22/1998WO1998011090A3 3-alkyl-3-phenyl-piperidines
05/22/1998CA2272066A1 Certain pyrazole derivatives as corticotropin-releasing factor receptor crf1 specific ligands
05/22/1998CA2271832A1 Piperidine derivatives
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271272A1 5-ht1f agonists
1 ... 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 ... 1833